NCT02225704View on ClinicalTrials.gov

Radium-223 in Combination With Enzalutamide

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

November 23, 2021

Conditions
Prostate Cancer
Interventions
DRUG

Radium-223 and enzalutamide

Trial Locations (7)

Unknown

Cork University Hospital, Cork

Mater Misericordiae University Hospital, Dublin

Mater Private Hospital, Dublin

SLRON, St James's Hospital, Dublin

St Vincents University Hospital / AMNCH, Dublin

Tallaght Hospital, Dublin

Galway University Hospital, Galway

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT02225704 - Radium-223 in Combination With Enzalutamide | Biotech Hunter | Biotech Hunter